Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Friday Feb 21, 2025
Friday Feb 21, 2025
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts in breast cancer as they provide insights into the current guideline recommendations for the use of targeted therapy in patients with HR+/HER2– early breast cancer, evaluate the latest data for CDK4/6 inhibitors in this patient population and consider how to maximize the potential of these agents through risk stratification and safety considerations.
The experts
- Prof. Carlos Barrios: Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil
- Prof. Dr. med. Peter Fasching: University Hospital Erlangen and Comprehensive Cancer Center, Erlangen-EMN, Germany
- Dr Sonia Pernas: Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
This touchPODCAST is for healthcare professionals outside of the UK and the USA.
This activity is funded by an independent medical education grant from Novartis.
This activity is provided by touchIME.
For further information visit our website:
www.touchONCOLOGY.com
Thursday Feb 20, 2025
Thursday Feb 20, 2025
touchIN CONVERSATION for touchONCOLOGY
Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate vaccination schedules for specific patient groups, and strategies to improve vaccine uptake across various healthcare settings.
The experts
- Dr Barbara Moscicki, UCLA Health and University of California, Los Angeles, CA, USA
- Dr Marc Steben, HPV Global Action and Université de Montréal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/in-conversation-improving-hpv-vaccine-uptake/
Thursday Feb 20, 2025
Thursday Feb 20, 2025
touchIN CONVERSATION for touchINFECTIOUS DISEASES
Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate vaccination schedules for specific patient groups, and strategies to improve vaccine uptake across various healthcare settings.
The experts
- Dr Barbara Moscicki, UCLA Health and University of California, Los Angeles, CA, USA
- Dr Marc Steben, HPV Global Action and Université de Montréal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchinfectiousdiseasesime.org/in-conversation-improving-hpv-vaccine-uptake/
Tuesday Feb 18, 2025
Tuesday Feb 18, 2025
touchFOCUS for touchONCOLOGY
In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies.
The expert:
- Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Sanofi US.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchoncology.com
Tuesday Feb 18, 2025
Tuesday Feb 18, 2025
touchFOCUS for touchHAEMATOLOGY
In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies.
The expert:
- Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA
This touchPODCAST is for HCPs outside the UK.
This activity is funded by an independent medical education grant from Sanofi US.
This activity is jointly provided by USF Health and touchIME.
For further information visit our website: touchHAEMATOLOGY.com
Thursday Feb 06, 2025
Thursday Feb 06, 2025
touchCONGRESS for ONCOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/
Thursday Feb 06, 2025
Thursday Feb 06, 2025
touchCONGRESS for touchHAEMATOLOGY
Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of the data for clinical practice.
The experts
- Prof. Katja Weisel, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Dr Nisha Joseph, Emory University School of Medicine, Atlanta, GA, USA
- Prof. Roman Hájek, University Hospital Ostrava, Ostrava, Czech Republic
This touchPODCAST is for HCPs outside of the USA and UK.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/bcma-directed-therapies-in-multiple-myeloma-ash2024/
Thursday Jan 30, 2025
Thursday Jan 30, 2025
touchEXPERT OPINIONS for touchONCOLOGY
Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes.
The experts
- Dr David S Hong, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Dr Eileen M O’Reilly, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
- Dr Rebecca S Heist, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Revolution Medicines.
This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/mutations-and-personalized-cancer-care-targeting-the-future/
Wednesday Jan 29, 2025
Wednesday Jan 29, 2025
touchPANEL DISCUSSION for touchONCOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
- Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
- Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
- Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#
Wednesday Jan 29, 2025
Wednesday Jan 29, 2025
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exposition.
The experts
- Dr Hanny Al-Samkari – Massachusetts General Hospital, Boston, MA, USA
- Dr Drew Provan – Barts and The London School of Medicine and Dentistry, London, UK
- Dr Barbara Skopec – University Medical Centre Ljubljana, Ljubljana, Slovenia
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Sanofi.
This activity is jointly provided by USF Health and touchIME. TouchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchhaematologyime.org/itp-key-updates-from-ash-2024/#